Walleye Capital’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Walleye Capital’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-28,589	Closed	-$427K	–	4707
2022 Q4	$427K	Buy	+28,589	New	+$396K	0.01%	1554
2021 Q3	–	Sell	-21,813	Closed	-$144	–	2057
2021 Q2	$144	Buy	+21,813	New	+$150K	﹤0.01%	1121

Walleye Capital's AVEO Position: Q1 2023 in Review

Walleye Capital sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 28,589 shares — an estimated $427K sold.

Walleye Capital first reported a position in AVEO in Q2 2021 and held it in 2 quarters. The position peaked at $427K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Walleye Capital reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Walleye Capital sold 28,589 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $427K.
Walleye Capital first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
Walleye Capital's AVEO Pharmaceuticals, Inc. position peaked at $427K in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.